Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

Contributed by: Business Wire

Logo

Images

The report discloses PCI's performance, targets, and strategy to achieve nine identified impact categories. (Photo: Business Wire)

Business Wire embedded0

Tags

Medical Supplies

Biotechnology

Manufacturing

Professional Services

Health

General Health

Pharmaceutical

Environmental, Social and Governance (ESG)

Transport

Logistics/Supply Chain Management

Packaging

ESG Report

More Like This

PCI Pharma Services is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. (Photo: Business Wire)

PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products

Options Abound as Europe’s ESG Services Expand Rapidly

PCI becomes first drug product CDMO to navigate ICMRA multi-agency inspection process. (Photo: Business Wire)

PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection

PR Newswire associated0

Sigenergy's ESG Report: Driving Sustainability and Responsible Growth

Europe’s Demand for Digital Sustainability Solutions on the Rise

PR Newswire associated0

XCMG Machinery Unveils Groundbreaking ESG Report, Marking a Milestone in Sustainable Business Development

Finance Teams Prioritize ESG Reporting but Lack Adequate Technology, Finds insightsoftware Report

PR Newswire associated0

Clario delivers substantial gains toward diversity and net-zero emission goals in second annual ESG report